# BD Venture

> BD Venture is a VC fund in Dhaka backing Medical and Health Care. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Dhaka, Bangladesh
- Total investments: 5
- Last investment: Jan 2022
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/bdventure/
- Website: http://www.bdventure.com
- Facebook: http://www.facebook.com/bdventure

BD Venture is a VC fund in Dhaka focused on Medical and Health Care. BD Venture Limited, a Venture Capital Company, is an outcome of relentless effort from a group of leaders of the financial and entrepreneurial ecosystems of Bangladesh with a view to promoting innovative and potential seed, early & growth stage entrepreneurs & enterprises to pave their expansion through facilitating investment, consultancy& other relevant services. We are capable to address and accommodate the undulations of a venture and tailor our & the investee enterprise’s shape to adapt with a perspective approach. We have adopted innovative ways of investment for those entrepreneurs or enterprises for who the doors of the conventional financing institutions are hardly open.

## Contacts

5 contacts available for BD Venture. Shizune tracks 2 team members at BD Venture. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/bd-ventures?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 40% |
| Health Care | 2 | 40% |
| Biotechnology | 2 | 40% |
| EdTech | 1 | 20% |
| Diabetes | 1 | 20% |

17 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Funding Round | 2 | 40% |
| Pre-Seed | 1 | 20% |
| Series B | 1 | 20% |
| Venture - Series Unknown | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Bangladesh | 3 | 60% |
| United States | 2 | 40% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Abdul Hafiz Choudhury | Founder | 0 | https://shizune.co/investors/profile/abdul-hafiz-choudhury |
| Shawkat Hossain | Managing Director | 0 | https://shizune.co/investors/profile/shawkat-hossain |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| AmarSource | AmarSource is a R&D company that takes on challenges to solve engineering problems. |  | Venture - Series Unknown | Jan 31, 2022 |  |
| E-Desh | E-Desh is an E-Commerce Logistics Company that provides integrated logistic solutions with experience, capabilities, functional expertise, technological embedment. |  | Series B | Dec 28, 2021 |  |
| Esho Shikhi | Eshosikhi.com is an one stop online platform providing students with 360 degree solution.Students of Bangladesh can take preparation on K12 education, university entrance exam and job preparation in this platform. |  | Pre-Seed | Nov 05, 2019 |  |
| RenaMed Biologics | RenaMed Biologics a biotechnology company, engages in the development and commercialization of therapies for the treatment of diseases associated with compromised kidney function. The company focuses on patients suffering from acute renal failure and additional indications where kidney function is compromised. It develops RBI-01, which utilizesphysiologically active human renal epithelial cells and administered ex vivo, to replace and maintain severely compromised, or lost kidney functions due to illness, or trauma. The company was founded in 1995 as Nephros Therapeutics, Inc. and changed its name to RenaMed Biologics, Inc. in 2005. RenaMed Biologics, Inc. is based in Lincoln, Rhode Island. | $40M |  | Sep 07, 2006 |  |
| ViaCyte | ViaCyte is a preclinical therapeutic company specializing in regenerative medicine therapies for diabetes. Their therapy is based on the differentiation of stem cells into pancreatic beta-cell precursors, with subcutaneous implantation in an encapsulation device. Data in their publications demonstrate that these cells can produce therapeuticallyrelevant levels of insulin in response to blood glucose, and sustain diabetic animals. Their goal is a product which can free both Type 1 and Type 2 patients with diabetes from insulin dependence on a long-term basis, while reducing or eliminating hypoglycemic, microvasculature, and weight-related cardiovascular complications. | $20M |  | May 03, 2006 |  |

5 of 5 investments shown.

## Co-investors
- [Apjohn ventures](https://shizune.co/investors/profile/apjohn-ventures) — VC Fund, 1 deal together
- [Asset Management Ventures (AMV)](https://shizune.co/investors/profile/asset-management-ventures) — VC Fund, 1 deal together
- [Bangladesh Angels](https://shizune.co/investors/profile/bangladesh-angels) — VC Fund, 1 deal together
- [DFJ Portage Ventures](https://shizune.co/investors/profile/dfj-portage-ventures) — VC Fund, 1 deal together
- [EDBI](https://shizune.co/investors/profile/edbi) — VC Fund, 1 deal together
- [Headland Ventures](https://shizune.co/investors/profile/headland-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar industry
- [Reach Capital](https://shizune.co/investors/profile/reach-capital) — VC Fund
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [GSV Ventures](https://shizune.co/investors/profile/gsv-acceleration) — VC Fund

### Similar stage
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [HTGF (High-Tech Gruenderfonds)](https://shizune.co/investors/profile/high-tech-gr%C3%BCnderfonds) — VC Fund

### Similar country
- [SBK](https://shizune.co/investors/profile/sbk-tech-ventures) — VC Fund
- [Orbit Ventures](https://shizune.co/investors/profile/orbit-ventures) — VC Fund
- [Bangladesh Angels](https://shizune.co/investors/profile/bangladesh-angels) — VC Fund

## Featured in investor lists
- [All VC Funds in Bangladesh](https://shizune.co/investors/vc-funds-bangladesh)
- [Software Investors in Bangladesh](https://shizune.co/investors/software-investors-bangladesh)
- [EdTech Investors in Bangladesh](https://shizune.co/investors/edtech-investors-bangladesh)
- [SaaS Investors in Bangladesh](https://shizune.co/investors/saas-investors-bangladesh)
- [SaaS VC Funds in Bangladesh](https://shizune.co/investors/saas-vc-funds-bangladesh)
- [Education Investors in Bangladesh](https://shizune.co/investors/education-investors-bangladesh)

## FAQ

### What does BD Venture invest in?

BD Venture invests primarily in Medical, Health Care and Biotechnology startups, most often at Funding Round and Pre-Seed stage. Most of the 5 investments tracked by Shizune back companies in Bangladesh. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact BD Venture?

Public channels for BD Venture include LinkedIn, the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at BD Venture?

The team at BD Venture includes Abdul Hafiz Choudhury (Founder) and Shawkat Hossain (Managing Director). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co